scholarly journals Real-world Data and Recommended Dosage of Non-vitamin K Oral Anticoagulants for Korean Patients

2017 ◽  
Vol 47 (6) ◽  
pp. 833 ◽  
Author(s):  
Boyoung Joung
Stroke ◽  
2019 ◽  
Vol 50 (Suppl_1) ◽  
Author(s):  
Woo-Keun Seo ◽  
Joon-Tae Kim ◽  
Jong-Won Chung ◽  
Tae-Jin Song ◽  
Yong-Jae Kim ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (8) ◽  
pp. e0135054 ◽  
Author(s):  
Merlijn W. J. van Leent ◽  
Jelena Stevanović ◽  
Frank G. Jansman ◽  
Maarten J. Beinema ◽  
Jacobus R. B. J. Brouwers ◽  
...  

2021 ◽  
Vol 47 (02) ◽  
pp. 150-160
Author(s):  
Francesca Renon ◽  
Anna Rago ◽  
Biagio Liccardo ◽  
Antonello D'Andrea ◽  
Lucia Riegler ◽  
...  

AbstractMeasurement of direct oral anticoagulants (DOACs) activity is not routinely necessary. Indeed, evaluation of DOACs plasmatic concentration is discouraged for the majority of patients, due to the lack of outcome data supporting this approach. Nevertheless, DOAC measurements may be useful in emergency situations such as serious bleeding events, need for urgent invasive procedures, and acute ischemic stroke or in managing anticoagulation in “special populations” not adequately studied in clinical trials, for example the very elderly or those at the extremes of body weight. The aim of this review is to describe and summarize the methods for DOACs activity evaluation and the settings in which their plasma level measurement may be indicated, analyzing indications from scientific societies and evidence from clinical trials, as well as real world data on the usefulness of DOACs plasma levels “monitoring.”


2018 ◽  
Vol 24 (5) ◽  
pp. 440-448 ◽  
Author(s):  
Clara L. Rodriguez-Bernal ◽  
Salvador Peiró ◽  
Isabel Hurtado ◽  
Aníbal García-Sempere ◽  
Gabriel Sanfélix-Gimeno

Sign in / Sign up

Export Citation Format

Share Document